...
首页> 外文期刊>Diabetes therapy >Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial
【24h】

Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial

机译:Canagliflozin联合磺脲类药物在2型糖尿病患者中的疗效和安全性:一项随机对照试验

获取原文
           

摘要

Introduction The efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, was evaluated in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on sulfonylurea monotherapy.
机译:简介在磺脲类药物单一疗法控制不充分的2型糖尿病(T2DM)患者中,评估了钠葡萄糖共转运蛋白2(SGLT2)抑制剂canagliflozin的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号